FindTrial
Sign In

A scientific trail to evaluate the effect of a 13 week long lifestyle change program, anchored in the science of yoga i.e Swasth Wellness Program (SWP), on the systolic blood pressure, in subjects who are not on any anti-hypertensive treatment.

Investigator Initiated Trial to evaluate the efficacy of a 13 week long lifestyle change program, anchored in the science of yoga i.e Swasth Wellness Program (SWP), on the systolic blood pressure, in subjects who are not on any anti-hypertensive treatment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031779
Enrollment
160
Registered
2021-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intervention Arm: The subjects in intervention arm will attend the SWP for a period of 13 weeks Control Intervention1: Comparator Arm: The subjects in the control arm will be provided w

Sponsors

Mr Sundeep Kapalia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. SBP greater than or equal to 140 and less than 160 mmHg in right upper limb in sitting position 2. BMI less than 30 kg per square meter 3. Age more than or equal to 18 years and less than 60 years 4. Male and female subjects 5. Subjects willing to refrain from taking antihypertensive medication for the duration of the trial 6. Subjects willing to give voluntary informed consent

Exclusion criteria

Exclusion criteria: 1. Age greater than 60 years 2. Subjects on anti-hypertensive medication 3. SBP greater than 160 mmHg or DBP greater than 100 mmHg 4. Pregnant women 5. Subjects with diagnosed diabetes mellitus 6. Subjects with established cardiovascular disease renal disease or any severe systemic illness 7. Alcohol drinkers (More than 2 pegs per day) 8. Tobacco Users (cigarettes, gutka, tobacco) 9. Taking medication that affects BP.

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study will be the mean change in the SBP measured at baseline and 13 weeks for the two arms (interventional program group and no interventional program group).Timepoint: Two Visits—

Secondary

MeasureTime frame
1. Safety of the subject 2. Difference in mean in the DBP measured at baseline and 13 weeks 3. Mean change in BMI measured at baseline and 13 weeks 4. Difference in mean CVD Risk score as per Globorisk Office Scale 5. Difference in mean score on the 4 Swasth Kosha Scales of the SWPTimepoint: Two Visits—

Countries

India

Contacts

Public ContactMr Sundeep Kapila

Swasth Foundation

sundeep@swasth.org9820441957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026